These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3122273)

  • 1. Alpha chain unsaturated derivatives of misoprostol.
    Collins PW; Gasiecki AF; Weier RM; Kramer SW; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
    Prostaglandins; 1987; 33 Suppl():17-28. PubMed ID: 3122273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and gastrointestinal pharmacology of a 3E,5Z diene analogue of misoprostol.
    Collins PW; Kramer SW; Gasiecki AF; Weier RM; Jones PH; Gullikson GW; Bianchi RG; Bauer RF
    J Med Chem; 1987 Jan; 30(1):193-7. PubMed ID: 3100798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol.
    Collins PW; Gasiecki AF; Jones PH; Bauer RF; Gullikson GW; Woods EM; Bianchi RG
    J Med Chem; 1986 Jul; 29(7):1195-201. PubMed ID: 3100795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and synthetic development of misoprostol.
    Collins PW; Pappo R; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):114S-117S. PubMed ID: 3932041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-cycloalkyl analogues of enisoprost.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF
    J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
    Bertaccini G; Adami M; Coruzzi G
    Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four-hour intragastric measurements in twenty healthy subjects: effect of enisoprost, a novel and potent antisecretory and antipeptic synthetic E1 prostaglandin.
    Thomson AB; McCullough HN; Kirdeikis P; Zuk L; Simpson I; Cook DJ; Wildeman RA; Brunet K; Fisher D; Pinchbeck B
    Aliment Pharmacol Ther; 1988 Aug; 2(4):325-36. PubMed ID: 2979255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE
    Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.
    Davis GR; Fordtran JS; Dajani EZ
    Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of misoprostol on gastric acid and mucus secretion in man.
    Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of acyclic omega chain conjugated diene analogues of enisoprost.
    Collins PW; Shone RL; Perkins WE; Gasiecki AF; Kalish VJ; Kramer SW; Bianchi RG
    J Med Chem; 1992 Feb; 35(4):694-704. PubMed ID: 1542096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells.
    Tsai BS; Kessler LK; Collins P; Kramer S; Bauer RF
    Prostaglandins; 1987; 33 Suppl():30-9. PubMed ID: 2827238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Monk JP; Clissold SP
    Drugs; 1987 Jan; 33(1):1-30. PubMed ID: 3102205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol: discovery, development, and clinical applications.
    Collins PW
    Med Res Rev; 1990; 10(2):149-72. PubMed ID: 2109814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogues of enisoprost. Identification of a promising new antiulcer prostaglandin.
    Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Bianchi RG; Kramer SW; Ng JS; Yonan EE; Swenton L; Jones PH
    J Med Chem; 1990 Oct; 33(10):2784-93. PubMed ID: 2213831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and gastrointestinal pharmacology of the 4-fluoro analogue of enisoprost.
    Collins PW; Kramer SW; Gullikson GW
    J Med Chem; 1987 Nov; 30(11):1952-5. PubMed ID: 3669004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
    Silverstein FE; Kimmey MB; Saunders DR; Levine DS
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.